Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in Early Psychosis
NCT04317807Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Aug 2020
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levetiracetam in psychosis, sponsored by NYU Langone Health. Started Aug 2020; status: completed.
02
Drugs
levetiracetam
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT04317807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04317807.